Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Gruel

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Annales De Medecine Interne|January 1, 1987
[Blood and tumor eosinophilia associated with non-hematopoietic cancers: etiology, prognosis and physiopathology]J M Oliver, Y Bacq, Y Gruel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 26, 2007
Heparin-induced thrombocytopenia: a frequent complication after cardiac surgeryC Pouplard, S Regina, M-A May, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alphaS Regina, P Colombat, B Fimbel, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Biological monitoring of low molecular weight heparin. Value of a new chronometric tests, the Heptest]B Delahousse, Y Gruel, P Moalic, et al.
The Journal of Rheumatology|October 1, 1994
Antiphospholipid and anti-beta 2 glycoprotein I antibodies in monozygotic twin sistersR Cevallos, L Darnige, J Arvieux, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosisS Regina, O Herault, L D'Alteroche, et al.
Thrombosis Research|April 15, 1987
Comparative efficacy of a new clot-based anti-Xa/IIa assay and an amidolytic anti-Xa method during a very low molecular weight heparin fragment (CY 222) treatmentB Delahousse, Y Gruel, P Moalic, et al.
Thrombosis Research|September 26, 2002
Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudinE Mazoyer, L Drouet, B Delahousse, et al.
The Journal of Experimental Medicine|December 1, 1994
Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3Y Gruel, E Brojer, D J Nugent, et al.
Thrombosis Research|May 22, 2003
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell lineF Hubé, P Reverdiau, S Iochmann, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Annales De Medecine Interne|January 1, 1987
[Blood and tumor eosinophilia associated with non-hematopoietic cancers: etiology, prognosis and physiopathology]J M Oliver, Y Bacq, Y Gruel, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 26, 2007
Heparin-induced thrombocytopenia: a frequent complication after cardiac surgeryC Pouplard, S Regina, M-A May, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 14, 2001
Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alphaS Regina, P Colombat, B Fimbel, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Biological monitoring of low molecular weight heparin. Value of a new chronometric tests, the Heptest]B Delahousse, Y Gruel, P Moalic, et al.
The Journal of Rheumatology|October 1, 1994
Antiphospholipid and anti-beta 2 glycoprotein I antibodies in monozygotic twin sistersR Cevallos, L Darnige, J Arvieux, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosisS Regina, O Herault, L D'Alteroche, et al.
Thrombosis Research|April 15, 1987
Comparative efficacy of a new clot-based anti-Xa/IIa assay and an amidolytic anti-Xa method during a very low molecular weight heparin fragment (CY 222) treatmentB Delahousse, Y Gruel, P Moalic, et al.
Thrombosis Research|September 26, 2002
Activated partial thromboplastin time is more sensitive than ecarin clotting time for monitoring low doses of desirudinE Mazoyer, L Drouet, B Delahousse, et al.
The Journal of Experimental Medicine|December 1, 1994
Further characterization of the thrombasthenia-related idiotype OG. Antiidiotype defines a novel epitope(s) shared by fibrinogen B beta chain, vitronectin, and von Willebrand factor and required for binding to beta 3Y Gruel, E Brojer, D J Nugent, et al.
Thrombosis Research|May 22, 2003
Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell lineF Hubé, P Reverdiau, S Iochmann, et al.
Pageof 14